Bexson Biomedical is developing a non-opioid therapy for chronic and acute pain management based upon a unique formulation of ketamine for subcutaneous delivery. Ketamine is an anesthetic with powerful pain relieving properties. Bexson is is solving the pharmacokinetic issues presented by this useful molecule to allow exquisite control over dosing and achieve pain relief in multiple pain disorders. A safe and effective low-dose ketamine strategy for use in the home environment will be a game changer for difficult to treat pain conditions. It would reimagine pain management.